vs
Side-by-side financial comparison of CARLSMED, INC. (CARL) and SS Innovations International, Inc. (SSII). Click either name above to swap in a different company.
SS Innovations International, Inc. is the larger business by last-quarter revenue ($14.5M vs $13.1M, roughly 1.1× CARLSMED, INC.). SS Innovations International, Inc. runs the higher net margin — -17.0% vs -65.2%, a 48.2% gap on every dollar of revenue. SS Innovations International, Inc. produced more free cash flow last quarter ($-3.2M vs $-8.6M).
SS Innovations International, Inc. is a global medical technology enterprise specializing in the research, development and manufacturing of innovative surgical robotic systems. It provides high-precision, accessible robotic platforms for minimally invasive surgery, catering to healthcare facilities across multiple regions to boost surgical outcomes and cut procedural burdens.
CARL vs SSII — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.1M | $14.5M |
| Net Profit | $-8.5M | $-2.5M |
| Gross Margin | 75.9% | 43.9% |
| Operating Margin | -69.1% | -3.7% |
| Net Margin | -65.2% | -17.0% |
| Revenue YoY | — | 79.1% |
| Net Profit YoY | — | -28.5% |
| EPS (diluted) | $-0.40 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $14.5M | ||
| Q3 25 | $13.1M | $12.8M | ||
| Q2 25 | $12.1M | $10.0M | ||
| Q1 25 | — | $5.1M | ||
| Q4 24 | — | $8.1M | ||
| Q3 24 | — | $4.4M | ||
| Q2 24 | — | $4.5M | ||
| Q1 24 | — | $3.6M |
| Q4 25 | — | $-2.5M | ||
| Q3 25 | $-8.5M | $-3.7M | ||
| Q2 25 | $-6.8M | $-256.7K | ||
| Q1 25 | — | $-5.7M | ||
| Q4 24 | — | $-1.9M | ||
| Q3 24 | — | $-3.2M | ||
| Q2 24 | — | $-4.1M | ||
| Q1 24 | — | $-9.8M |
| Q4 25 | — | 43.9% | ||
| Q3 25 | 75.9% | 48.1% | ||
| Q2 25 | 73.4% | 59.1% | ||
| Q1 25 | — | 21.2% | ||
| Q4 24 | — | 48.9% | ||
| Q3 24 | — | 52.8% | ||
| Q2 24 | — | 31.9% | ||
| Q1 24 | — | 20.0% |
| Q4 25 | — | -3.7% | ||
| Q3 25 | -69.1% | -14.3% | ||
| Q2 25 | -53.8% | 1.0% | ||
| Q1 25 | — | -115.6% | ||
| Q4 24 | — | -22.7% | ||
| Q3 24 | — | -73.1% | ||
| Q2 24 | — | -90.9% | ||
| Q1 24 | — | -270.3% |
| Q4 25 | — | -17.0% | ||
| Q3 25 | -65.2% | -29.0% | ||
| Q2 25 | -56.0% | -2.6% | ||
| Q1 25 | — | -111.0% | ||
| Q4 24 | — | -23.7% | ||
| Q3 24 | — | -74.0% | ||
| Q2 24 | — | -91.8% | ||
| Q1 24 | — | -270.5% |
| Q4 25 | — | $-0.01 | ||
| Q3 25 | $-0.40 | $-0.02 | ||
| Q2 25 | $-1.47 | $0.00 | ||
| Q1 25 | — | $-0.03 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | — | $-0.02 | ||
| Q2 24 | — | $-0.02 | ||
| Q1 24 | — | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $115.4M | $3.2M |
| Total DebtLower is stronger | $15.4M | — |
| Stockholders' EquityBook value | $106.7M | $38.2M |
| Total Assets | $134.9M | $74.2M |
| Debt / EquityLower = less leverage | 0.14× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.2M | ||
| Q3 25 | $115.4M | $5.7M | ||
| Q2 25 | $33.5M | $11.4M | ||
| Q1 25 | — | $15.9M | ||
| Q4 24 | — | $466.5K | ||
| Q3 24 | — | $220.4K | ||
| Q2 24 | — | $608.2K | ||
| Q1 24 | — | $948.1K |
| Q4 25 | — | — | ||
| Q3 25 | $15.4M | — | ||
| Q2 25 | $15.4M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $38.2M | ||
| Q3 25 | $106.7M | $39.6M | ||
| Q2 25 | $-83.1M | $42.0M | ||
| Q1 25 | — | $40.6M | ||
| Q4 24 | — | $13.5M | ||
| Q3 24 | — | $13.7M | ||
| Q2 24 | — | $14.8M | ||
| Q1 24 | — | $16.7M |
| Q4 25 | — | $74.2M | ||
| Q3 25 | $134.9M | $69.6M | ||
| Q2 25 | $53.3M | $70.0M | ||
| Q1 25 | — | $63.5M | ||
| Q4 24 | — | $42.4M | ||
| Q3 24 | — | $39.0M | ||
| Q2 24 | — | $35.7M | ||
| Q1 24 | — | $35.2M |
| Q4 25 | — | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.5M | $-1.5M |
| Free Cash FlowOCF − Capex | $-8.6M | $-3.2M |
| FCF MarginFCF / Revenue | -65.9% | -22.3% |
| Capex IntensityCapex / Revenue | 1.2% | 11.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-22.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.5M | ||
| Q3 25 | $-8.5M | $-7.5M | ||
| Q2 25 | $-15.2M | $-3.5M | ||
| Q1 25 | — | $-6.1M | ||
| Q4 24 | — | $-3.3M | ||
| Q3 24 | — | $-2.5M | ||
| Q2 24 | — | $-1.0M | ||
| Q1 24 | — | $-2.7M |
| Q4 25 | — | $-3.2M | ||
| Q3 25 | $-8.6M | $-8.2M | ||
| Q2 25 | $-15.6M | $-3.8M | ||
| Q1 25 | — | $-7.0M | ||
| Q4 24 | — | $-3.4M | ||
| Q3 24 | — | $-4.2M | ||
| Q2 24 | — | $-3.1M | ||
| Q1 24 | — | $-2.8M |
| Q4 25 | — | -22.3% | ||
| Q3 25 | -65.9% | -64.1% | ||
| Q2 25 | -129.2% | -37.7% | ||
| Q1 25 | — | -136.2% | ||
| Q4 24 | — | -41.7% | ||
| Q3 24 | — | -96.9% | ||
| Q2 24 | — | -69.5% | ||
| Q1 24 | — | -76.9% |
| Q4 25 | — | 11.8% | ||
| Q3 25 | 1.2% | 5.9% | ||
| Q2 25 | 3.4% | 3.2% | ||
| Q1 25 | — | 17.0% | ||
| Q4 24 | — | 1.5% | ||
| Q3 24 | — | 38.8% | ||
| Q2 24 | — | 46.8% | ||
| Q1 24 | — | 3.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CARL
Segment breakdown not available.
SSII
| System Sales | $13.4M | 92% |
| Other | $1.2M | 8% |
